Panel Discussion: Exploring the Potential of Soluble TCR Therapies to Redirect and Activate T Cells

Time: 1:00 pm
day: Day Two


  • How do we enhance receptor-target interactions to develop safe and efficacious soluble TCR products?
  • Beyond survival benefit, how do we define the clinical response rate to determine success in phase 3 clinical trials?
  • What are the lessons that we have taken from antibodies?